Hooper Holmes reports 1% decline in consolidated revenues for Q4 2013

NewsGuard 100/100 Score

Hooper Holmes, Inc. (NYSE MKT:HH) today announced financial results for the year ended December 31, 2013.

On September 30, 2013, the Company closed on the sale of its Portamedic service line. As a result, financial results related to the Portamedic service line are reported as discontinued operations.

Consolidated revenues from continuing operations totaled $15.0 million for the fourth quarter of 2013, representing a 1% decline compared to $15.2 million in the fourth quarter of 2012. The Company recorded a net loss of $2.0 million, or $(0.03) per share, for the fourth quarter of 2013 compared to a net loss of $6.7 million, or $(0.10) per share, for the fourth quarter of 2012. The net loss for the fourth quarter of 2013 included a loss from discontinued operations of $0.5 million. The net loss for the fourth quarter of 2012 included a loss of $5.7 million from discontinued operations.

For the year ended December 31, 2013, consolidated revenues from continuing operations were $49.2 million, a decline of approximately 3.5% compared to $51.0 million for the full year 2012. The Company's net loss for the year ended December 31, 2013 totaled $11.3 million, or $(0.16) per share, compared to a net loss of $17.6 million, or $(0.25) per share, for the year ended December 31, 2012. Results for the year ended December 31, 2013 included $0.8 million of restructuring charges related to continuing operations, $3.4 million gain on the sale of Portamedic, and a loss from discontinued operations of $4.5 million. The net loss for the year ended December 31, 2012 included $0.6 million of restructuring charges from continuing operations and a loss of $10.5 million from discontinued operations.

Full year 2013 revenues by segment:

  • Health & Wellness revenue totaled $23.1 million, an increase of 8% from $21.3 million in full year 2012.
  • Heritage Labs revenue totaled $11.4 million, a decline of approximately 13% compared to $13.2 million in full year 2012, primarily attributable to a decrease in revenue from the Company's life insurance lab testing services.
  • Hooper Holmes Services revenues totaled $14.6 million, a decline of approximately 11% compared to $16.5 million for 2012, primarily attributed to reduced demand for the Company's medical records collection services, and partially offset by increased revenues from underwriting services.

As of December 31, 2013, cash and cash equivalents totaled $4.0 million, with no borrowings outstanding under the Company's credit facility.

Commenting on 2013 financial results, Henry E. Dubois, President and CEO of Hooper Holmes, stated: "The 2013 fourth quarter marked a transition for Hooper Holmes that will continue through Q1 2014. The sale of Portamedic, which had been a source of losses, accelerated our drive to restructure and build a leaner, faster, less costly company, though transition costs will linger through Q1 2014. But when you peel away the impacts from the life insurance market, we are pleased to see our Health and Wellness business is growing, which will drive the Company forward and be the source of shareholder value creation."

Continued Mr. Dubois, "We believe we are well positioned for Health & Wellness growth in 2014 and beyond. We are pleased with the traction we are experiencing in the first quarter of 2014 and we are continuing to execute on initiatives to improve operational efficiencies."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.